HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...
Prif Awduron: | Goulbourne, C, Vaux, D |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Portland Press
2010
|
Eitemau Tebyg
-
The structural basis of ZMPSTE24-dependent laminopathies
gan: Quigley, A, et al.
Cyhoeddwyd: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
gan: Quigley, A, et al.
Cyhoeddwyd: (2013) -
Prelamin A and ZMPSTE24 in premature and physiological aging
gan: Howard J. Worman, et al.
Cyhoeddwyd: (2023-12-01) -
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
gan: Moritz Messner, et al.
Cyhoeddwyd: (2020-08-01) -
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
gan: Jemima Barrowman, et al.
Cyhoeddwyd: (2012-01-01)